SUBSTITUTED 4-(ARYLAMINO) SELENOPHENOPYRIMIDINE COMPOUNDS AND METHODS OF THEREOF APPLICATION Russian patent published in 2015 - IPC C07D517/04 C07D517/14 A61K31/95 A61K31/519 A61P35/00 

Abstract RU 2566293 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to selenophene compound of formula (I) or its pharmaceutically acceptable salt. X stands for selenium, Y and Z stand for carbon atoms; or Y stands for selenium, X and Z stand for carbon atoms; or Z stands for selenium, X and Y stand for carbon atoms; A stands for N; B stands for NR5, where R5 is selected from hydrogen, or alkyl; Ar stands for aryl or heteroaryl ring; aryl represents benzene or naphthalene ring, and heteroaryl represents 6-membered aromatic ring, which contains one, two or three nitrogen atoms; or heteroaryl stands for 5-membered aromatic ring, which contains one or several heteroatoms, selected from sulphur, oxygen and nitrogen, on condition that not more than one oxygen or sulphur atom is present; and such rings include pyridine, pyridazine, pyrazine, pyrimidine, thiophene, furan, pyrrole, pyrazole, imidazole, oxazole, isoxazole, thiazole and isothiazole; optionally substituted with one, two or several groups, independently selected from hydrogen, halogen, thiol, sulphonamide, C1-6alkyl, secondary C1-6alkyl, tertiary C1-6alkyl, C2-6alkinyl, C1-4alkoxycarbonyl and phenyl; R1, R2 and R3 are independently selected from hydrogen, carboxylic acid, amino, nitro, cyano, sulphonic acid, thiol, trihalomethyl, C1-6alkyl, secondary C1-6alkyl, tertiary C1-6alkyl, C1-4alkoxycarbonyl, aminocarbonyl, C1-6alkylaminocarbonyl, di(C1-6alkyl)aminocarbonyl, and phenyl; or R1 and R2 are bound, and together with atoms, which they are bound to, they form 5-7-membered optionally substituted carbocyclic or perhydroheterocyclic ring, given in invention formula; or R1 and R2 are bound, and together with atoms, which they are bound to, form optionally substituted aryl or non-substituted heteroaryl ring, fused with selenophene; and aryl represents benzene ring, and heteroaryl represents 6-membered aromatic ring, which contains one nitrogen atom. Methods of obtaining selenophene compound (versions), pharmaceutical composition, methods of treatment or inhibition, or control of cell proliferative disorder are also claimed.

EFFECT: invention makes it possible to obtain selenophene compound, which has anticancer activity.

29 cl, 2 tbl, 35 ex

Similar patents RU2566293C2

Title Year Author Number
SUBSTITUTED 4-(SELENOPHEN-2(OR 3)-YLAMINO) PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF 2011
  • Gokaradzhu Ganga Radzhu
  • Kasina Sudkhakar
  • Somepalli Venkatesvarlu
  • Gokaradzhu Rama Radzhu
  • Gokaradzhu Ventaka Kanaka Ranga Radzhu
  • Bkhupatkhiradzhu Kiran
  • Golakoti Trimurtulu
  • Sengupta Krishanu
  • Alluri Ventaka Krishna Radzhu
RU2597609C2
HETEROCYCLIC DERIVATIVES AND USE THEREOF 2015
  • Moon, Hyung Jo
  • Kong, Minjung
  • Kim, Mi Sun
  • Kim, Byungho
  • Kim, Hye Jung
  • Ko, Kwang Seok
  • Yun, Jee Hun
  • Park, Heon Kyu
  • Kim, Jungsook
  • Lee, Soon Ok
  • Im, Junhwan
  • Lee, Sang Hwi
  • Park, Chan Hee
RU2711502C2
NEW INHIBITOR BASED ON A QUINOLINE DERIVATIVE 2019
  • Wu, Frank
  • Wan, Zhonghui
RU2802283C2
FGFR4 INHIBITORS 2014
  • Rejnolds Dominik
  • Khao Min-Khun
  • Van Dzhon
  • Pradzhapati Sudip
  • Satokh Takasi
  • Selvaradzh Anand
RU2715708C2
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF 2016
  • Patel Snakhel
  • Gamilton Gregori
  • Stivala Krejg
  • Chen Khuejfen
  • Chzhao Gujlin
RU2716136C2
SERINE/THREONINE KINASE INHIBITORS 2013
  • Blejk Dzhejms F.
  • Chikarelli Mark Jozef
  • Gerri Rustam Ferdinand
  • Gaudino Dzhon
  • Grina Dzhonas
  • Moreno Devid A.
  • Mor Peter Dzh.
  • Ren Li
  • Shvarts Dzhejkob
  • Chen Khuejfen
  • Robardzh Kirk
  • Chzhou Ajkhe
RU2650501C2
HETEROARYL COMPOUNDS AS IRAK TYPE II INHIBITORS AND THEIR USE 2019
  • Jorand-Lebrun, Catherine
  • Brugger, Nadia
  • Johnson, Theresa
RU2810338C2
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY 2011
  • Cha Mi Yang
  • Kang Seok Dzong
  • Kim Mi Ra
  • Li Dzu Jeon
  • Dzeon Dzi Yang
  • Dzo Mioung Gi
  • Kvak Eun Dzoo
  • Li Kvang Ok
  • Kha Tae Khee
  • Sukh Kvee Khiun
  • Kim Maeng Sup
RU2585177C2
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS 2005
  • Lim Sungtaek
  • Kharris Kejt Dzhon
  • Stefani Dehvid
  • Gardner Charl'Z Dzh.
  • Tsao Bin
  • Boffi Rehj
  • Gillespi Timoti A.
  • Agiar Zhuasi K.
  • Khant Khejzel Dzh.
  • Desho Ehl'Za A.
RU2417990C2
PROTEIN TYROSINE KINASE MODULATORS AND METHODS OF USE 2014
  • Hu, Shaojing
  • Liu, Xiangyong
  • Bai, Jinlong
  • Long, Wei
RU2656591C2

RU 2 566 293 C2

Authors

Gokaradzhu Ganga Radzhu

Kasina Sudkhakar

Somepalli Venkatesvarlu

Gokaradzhu Rama Radzhu

Gokaradzhu Venkata Kanaka Ranga Radzhu

Bkhupatkhiradzhu Kiran

Golakoti Trimurtulu

Sengupta Krishanu

Alluri Venkata Krishna Radzhu

Dates

2015-10-20Published

2011-12-07Filed